SUZHOU HOMESUN WANQING PHARMACEUTICAL CO LTD
Overview
SUZHOU HOMESUN WANQING PHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering CEFMETAZOLE SODIUM; IMIPENEM AND CILASTATIN FOR INJECTION STERILE BULK; MEROPENEM FOR INJECTION STERILE BULK.
Core services & business areas
API / Drug Master Files
SUZHOU HOMESUN WANQING PHARMACEUTICAL CO LTD holds 2 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- IMIPENEM AND CILASTATIN FOR INJECTION STERILE BULKActive2010-07-09
- MEROPENEM FOR INJECTION STERILE BULKActive2009-11-24
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to SUZHOU HOMESUN WANQING PHARMACEUTICAL CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this SUZHOU HOMESUN WANQING PHARMACEUTICAL CO LTD? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.